| CYSB2100054 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2021-02-05 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | In Review | 2022-01-25 | view |
| JYSB2100048 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | | In Review | 2021-02-18 | view |
| JYSB2100047 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | | In Review | 2021-02-18 | view |
| JYSB2100046 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | | In Review | 2021-02-18 | view |
| JYSB2100045 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-02-19 | | | In Review | 2021-02-18 | view |
| JYSB2000400 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | | Filed | 2020-09-15 | view |
| JYSB2000399 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | | Filed | 2020-09-15 | view |
| JYSB2000398 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | | Filed | 2020-09-15 | view |
| JYSB2000397 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | | Filed | 2020-09-15 | view |
| JYSB2000374 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | | Filed | 2020-08-19 | view |
| JYSB2000373 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | | Filed | 2020-08-19 | view |
| JYSB2000372 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | | Filed | 2020-08-19 | view |
| JYSB2000371 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2020-08-10 | | | Filed | 2020-08-19 | view |
| CXSS1800007 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(7) | New Drug Application | 2018-04-16 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | Certificate Issued | 2020-07-16 | view |
| CXSS1900050 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(7) | New Drug Application | 2019-12-26 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | In Review | 2019-12-25 | view |
| JYSB1800270 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | | Certificate Issued | 2019-12-20 | view |
| JYSB1800273 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | | Certificate Issued | 2019-12-20 | view |
| JYSB1800272 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | | Certificate Issued | 2019-12-20 | view |
| JYSB1800271 | 注射用重组人凝血因子Ⅸ | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2018-12-03 | | | Certificate Issued | 2019-12-20 | view |
| JXSS1900064 | 注射用重组人凝血因子IX -Fc融合蛋白 | eftrenonacog alfa | Lyophilized | Biological Products | Import Drug Application | 2019-11-27 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | In Review | 2019-12-14 | view |
